HIV Treatment as Prevention: Principles of Good HIV Epidemiology Modelling for Public Health Decision-Making in All Modes of Prevention and Evaluation

English version České info

Public health responses to HIV epidemics have long relied on epidemiological modelling analyses to help prospectively project and retrospectively estimate the impact, cost-effectiveness, affordability, and investment returns of interventions, and to help plan the design of evaluations. But translating model output into policy decisions and implementation on the ground is challenged by the differences in background and expectations of modellers and decision-makers. As part of the PLoS Medicine Collection “Investigating the Impact of Treatment on New HIV Infections”—which focuses on the contribution of modelling to current issues in HIV prevention—we present here principles of “best practice” for the construction, reporting, and interpretation of HIV epidemiological models for public health decision-making on all aspects of HIV. Aimed at both those who conduct modelling research and those who use modelling results, we hope that the principles described here will become a shared resource that facilitates constructive discussions about the policy implications that emerge from HIV epidemiology modelling results, and that promotes joint understanding between modellers and decision-makers about when modelling is useful as a tool in quantifying HIV epidemiological outcomes and improving prevention programming.

Vyšlo v časopise: HIV Treatment as Prevention: Principles of Good HIV Epidemiology Modelling for Public Health Decision-Making in All Modes of Prevention and Evaluation. PLoS Med 9(7): e32767. doi:10.1371/journal.pmed.1001239
Kategorie: Review
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001239

Souhrn

Zdroje

1. RileySFraserCDonnellyCAGhaniACAbu-RaddadLJ 2003 Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 300 1961 1966

2. FraserCDonnellyCACauchemezSHanageWPVan KerkhoveMD 2009 Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324 1557 1561

3. GrasslyNCFraserCWengerJDeshpandeJMSutterRW 2006 New strategies for the elimination of polio from India. Science 314 1150 1153

4. GriffinJTHollingsworthTDOkellLCChurcherTSWhiteM 2010 Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med 7 e1000324 doi:10.1371/journal.pmed.1000324

5. SalomonJAHoganDRStoverJStaneckiKAWalkerN 2005 Integrating HIV prevention and treatment: from slogans to impact. PLoS Med 2 e16 doi:10.1371/journal.pmed.0020016

6. SchwartlanderBStoverJHallettTAtunRAvilaC 2011 Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 377 2031 2041

7. EatonJWJohnsonLFSalomonJABärnighausenTBendavidE 2012 HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 9 e1001245 doi:10.1371/journal.pmed.1001245

8. GarnettGPCousensSHallettTBSteketeeRWalkerN 2011 Mathematical models in the evaluation of health programmes. Lancet 378 515 525

9. GrasslyNCFraserC 2008 Mathematical models of infectious disease transmission. Nat Rev Microbiol 6 477 487

10. WilsonDPGarnettGP 2011 Introductions to recent developments in HIV epidemic modelling. Curr Opin HIV AIDS 6 91 93

11. KeelingMJRohaniP 2007 Modeling infectious diseases in humans and animals Princeton Princeton University Press

12. VynnyckyEWhiteR 2010 An Introduction to Infectious Disease Modelling Oxford Oxford University Press

13. HankinsCAGlasserJWChenRT 2011 Modeling the impact of RV144-like vaccines on HIV transmission Vaccine 29 6069 6071

14. McLeanARBlowerSM 1993 Imperfect vaccines and herd immunity to HIV. Proc Biol Sci 253 9 13

15. AndersonRHansonM 2005 Potential public health impact of imperfect HIV type 1 vaccines. J Infect Dis 191 S85 S96

16. SmithRJBodineENWilsonDPBlowerSM 2005 Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers. AIDS 19 413 421

17. FossAMVickermanPTHeiseLWattsCH 2003 Shifts in condom use following microbicide introduction: should we be concerned? AIDS 17 1227 1237

18. DesaiKSansomSLAckersMLStewartSRHallHI 2008 Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS 22 1829 1839

19. UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention 2009 Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med 6 e1000109 doi:10.1371/journal.pmed.1000109

20. DelvaWEatonJWMengFFraserCWhiteRG 2012 HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med 9 e1001258 doi:10.1371/journal.pmed.1001258

21. HallettTBGarnettGPMupanberiyiZGregsonS 2008 Measuring effectiveness in community randomized trials of HIV prevention. Int J Epidemiol 37 77 87

22. AlthausCLTurnerKMSchmidBVHeijneJCKretzschmarM 2012 Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data. J R Soc Interface 9 136 146

23. Models of Infectious Diseases Agent Study 2011 MIDAS model profiles. Available: https://www.epimodels.org/midas/modelProfilesFull.do. Accessed 1 December 2011

24. BaggaleyRFFergusonNMGarnettGP 2005 The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol 2 9

25. JohnsonLFHallettTBRehleTMDorringtonRE 2012 The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface E-pub ahead of print. doi:10.1098/rsif.2011.0826

26. PrestageGPMcCannPGrayRHoareADownI 2011 The development of Australia's national syphilis action plan is based in interdisciplinary research findings. Int J Interdiscip Soc Sci 5 239 261

27. GrayRTHeymerKJHoareAKwonJATheinHH 2009 What impact might the economic crisis have on HIV epidemics in Southeast Asia? Curr HIV Res 7 656 665

28. BlowerSMDowlatabadiH 1994 Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int Stat Rev 2 229 243

29. WilsonDPCoplanPMWainbergMABlowerSM 2008 The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proc Natl Acad Sci U S A 105 9835 9840

30. SmithRJOkanoJTKahnJSBodineENBlowerS 2010 Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco. Science 327 697 701

31. AlkemaLRafteryAEClarkSJ 2007 Probabilistic projections of HIV prevalence using Bayesian melding. Ann Appl Stat 1 229 248

32. JohnsonLDorringtonRBradshawDPillay-Van WykVRehleT 2009 Sexual behaviour patterns in South Africa and their association with the spread of HIV: insights from a mathematical model. Demogr Res 21 289 340 doi:10.4054/DemRes.2009.21.11

33. BoxGDraperNR 1987 Empirical model-building and response surfaces Oxford John Wiley & Sons

34. Abu-RaddadLJSchifferJTAshleyRMumtazGAlsallaqRA 2010 HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa. Epidemics 2 173 182

35. AndersonRMMayRM 1991 Infectious disease of humans: dynamics and control Oxford Oxford University Press

36. Abu-RaddadLJPatnaikPKublinJG 2006 Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 314 1603 1606

37. MarinoSHogueIBRayCJKirschnerDE 2008 A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol 254 178 196

38. Abu-RaddadLLonginiIM 2008 No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS 22 1055 1061

39. WilsonDPGarnettGP 2011 Introduction to recent developments in HIV epidemic modeling. Curr Opin HIV AIDS 6 91 93

40. The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group 2012 HIV treatment as prevention: models, data, and questions—Towards evidence-based decision-making. PLoS Med 9 e1001259 doi:10.1371/journal.pmed.1001259

41. LongEFBrandeauMLOwensDK 2010 The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med 153 778 789

42. AndersonJSWilsonDTempletonDJGrulichACarterR 2009 Cost-effectiveness of adult circumcision for HIV prevention in men who have sex with men in a resource-rich setting. J Infect Dis 200 1803 1812

43. VickermanPKumaranayakeLBalakirevaOGuinnessLArtyukhO 2006 The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine. Sex Transm Dis 33 S89 S102

44. AlistarSSOwensDKBrandeauML 2011 Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine. PLoS Med 8 e1000423 doi:10.1371/journal.pmed.1000423

45. DrummondMFJeffersonTO 1996 Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 313 275 283

46. Kaiser Family Foundation 2011 International AIDS assistance from donor governments: commitments & disbursements, 2002–2010. Available: http://facts.kff.org/chart.aspx?ch=946. Accessed 25 November 2011

47. CohenMSChenYQMcCauleyMGambleTHosseinipourMC 2011 Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365 493 505

48. GranichRMGilksCFDyeCDe CockKMWilliamsBG 2009 Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373 48 57

49. WagnerBGKahnJSBlowerS 2010 Should we try to eliminate HIV epidemics by using a ‘test and treat’ strategy? AIDS 24 775 776

50. HallettTBWhitePJGarnettGP 2007 Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation. Sex Transm Infect 83 i55 i60